| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0006826> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0016674> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0027651> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0033522> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0038111> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0039195> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0039215> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0040225> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0086692> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0242629> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0454831> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0949431> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C0949432> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C1956157> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32977223_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France.\', \'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000, Dijon, France; University of Burgundy Franche-Comté, F-21000, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France.\', \'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France.\', \'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000, Dijon, France; University of Burgundy Franche-Comté, F-21000, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France. Electronic address: fghiringhelli@cgfl.fr.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bon_Marjorie> <https://research.tib.eu/covid-19/entity/Fumet_Jean-David> <https://research.tib.eu/covid-19/entity/Ghiringhelli_Francois> <https://research.tib.eu/covid-19/entity/Hampe_L%C3%A9a> <https://research.tib.eu/covid-19/entity/Limagne_Emeric> <https://research.tib.eu/covid-19/entity/Thibaudin_Marion>
?:doi	<https://research.tib.eu/covid-19/entity/S0959-8049%2820%2930464-010.1016/j.ejca.2020.08.013>
?:doi	S0959-8049(20)30464-010.1016/j.ejca.2020.08.013
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	European journal of cancer (Oxford, England : 1990)
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32977223>
?:pmid	<https://research.tib.eu/covid-19/entity/32977223>
?:pmid	32977223
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0024312_COEXISTS_WITH_C1155266> <https://research.tib.eu/covid-19/entity/C0024312_PROCESS_OF_C1516213> <https://research.tib.eu/covid-19/entity/C1175175_PROCESS_OF_C1516213>
?:title	Immunological features of coronavirus disease 2019 in patients with cancer.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France.\', \'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000, Dijon, France; University of Burgundy Franche-Comté, F-21000, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France.\', \'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France.\', \'Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, F-21000, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000, Dijon, France; University of Burgundy Franche-Comté, F-21000, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France. Electronic address: fghiringhelli@cgfl.fr.\']

?:citedBy